Sudafed Class Action Lawsuit Filed Over “Ineffective” Decongestant in Cold Medications

Following a determination made last week by a panel of scientific advisors to the U.S. government, which found that the decongestant phenylephrine is no more effective than a placebo, a Minnesota woman has filed a class action lawsuit against the makers of Sudafed.

The complaint (PDF) was brought by Miesha McIntyre in the U.S. District Court for the District of Minnesota on September 15, seeking class action status to pursue damages on behalf of all consumers from the drug maker Kenvue, Inc. and McNeil Consumer Healthcare as defendants.

Both companies were previously owned by Johnson & Johnson, and comprised its over-the-counter consumer medication division. They have since been spun off into Kenvue, which is now a separate company that owns McNeil.

Sudafed Decongestant Does Not Work

Earlier this month, an advisory committee to the U.S. Food and Drug Administration (FDA) determined that the decongestant phenylephrine is ineffective when taken orally. Even though its been on the market for decades in popular products like Sudafed, Mucinex and Tylenol Cold and Flu tablets and liquids, recent data indicates it is no more effective than a placebo.

The FDA must now decide whether it should be allowed to remain on the market.

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

However, McIntyre’s lawsuit points out that she and other paid premium prices for expensive cold medications for decades which did not alleviate their decongestion.

Her lawsuit specifically targets Sudafed PE, which she indicates she used as recently as this month, but failed to experience decongestion relief. The reason why only became apparent after the FDA advisory committee’s findings were announced.

“Had Plaintiff known that the phenylephrine-containing Products were entirely ineffective as a nasal decongestant, she would not have purchased them, or would have paid substantially less for them,” the lawsuit states. “Accordingly, Plaintiff, on behalf of herself and all other consumers of Defendants’ phenylephrine products, seeks to hold Defendants accountable for their deceptions, breaches of warranties, and violations of Minnesota consumer protection statutes.”

The Sudafed class action lawsuit seeks to represent all persons in Minnesota who purchased an oral nasal decongestant containing phenylephrine manufactured by the defendants.

McIntyre accuses the manufacturers of breach of warranty, unjust enrichment, fraud by omission, and violation of various Minnesota consumer protection laws.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case.
An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe.
Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer.